- Name: Frank Harvey
- Previous title: Managing principle, ATLS Investments
- New title: Chief executive officer, Surescripts
As of June 27, Harvey will take over as CEO of e-prescription network Surescripts, the business announced on Monday. He succeeds Tom Skelton, who announced his retirement from Virginia-based Surescripts eight years ago.
Harvey is a pharmacist with more than three decades of experience in the healthcare industry. He has held a number of high leadership positions. The executive most recently oversaw ATLS Investments’ private equity investment in health tech firms.
Prior to that, Harvey held the positions of CEO of Liberty Medical Supply and the drug therapy management company Mirixa Corporation.
The Federal Trade Commission filed a lawsuit against Surescripts in 2019 over claimed anticompetitive actions, and the case is still ongoing. The health IT company, which is owned by Express Scripts, CVS Health, and two trade associations, is also aiming to improve the precision of electronic prescriptions and expand its provider connections.
The opportunity to join Surescripts at such a pivotal moment is an honour, and Harvey expressed his gratitude in a statement. “I look forward to working with the team to fulfil the great potential we have to improve healthcare,” Harvey added.
